Cite

HARVARD Citation

    Sakata, S. et al. (2016). Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301. Lung cancer. pp. 41-45. [Online]. 
  
Back to record